Industry & Hardware

Syrrx

acquired

Stage

About

Syrrx was a drug discovery company focused on structure-based drug design and high-throughput crystallography, acquired by Takeda in April 2005.

Funding rounds, investor list, and risk signals — unlock with a subscription.